Topic: sterile injectables
After a year of remediation, an Indian drugmaker has worked its way out from under an FDA warning letter issued for its sterile injectables operation.
AmerisourceBergen has received a grand jury subpoena to supply info to the DOJ about its testing of a syringe made at its PharMEDium lab in Tennessee.
Construction of German CDMO Vetter’s new sterile injectables manufacturing facility appears to be getting pushed back until 2022.
AbbVie is investing $139 million in a sterile manufacturing expansion and adding 100 jobs at its plant in Sligo to produce future cancer drugs.
Swedish CDMO Recipharm has decided to buy the piece of Indian sterile drugmaker Nitin Lifesciences that it doesn’t currently own.
A U.S. unit of Japan’s Daiichi Sankyo that makes sterile injectable drugs will invest $145 million to expand facilities in Ohio, adding 80 jobs in the process.
Xellia Pharmaceuticals is hiring at the former Ben Venue Labs in Bedford, Ohio, as it prepares to begin drug manufacturing at the site next year.
With plans for a major expansion of its site North Carolina, Fresenius Kabi's investments aimed mainly at the U.S. generics market now top $5 billion.
AmerisourceBergen has added $50 million more to resolve a DOJ probe into sales of cancer meds, taking its total in the matter to $885 million.
Manufacturing issues at legacy Hospira plants have taken a toll on Pfizer’s earnings and created serious problems for some of its clients.